Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -13.31
- Piotroski Score 3.00
- Grade Buy
- Symbol (ZEV)
- Company Lightning eMotors, Inc.
- Price $1.63
- Changes Percentage (-5.23%)
- Change -$0.09
- Day Low $1.61
- Day High $1.75
- Year High $38.40
Lightning eMotors, Inc. designs, manufactures, and sells zero-emission commercial fleet vehicles and powertrains to commercial fleets, large enterprises, original equipment manufacturers, and governments in the United States. It offers zero-emission class 3 to 7 battery electric and fuel cell electric vehicles. The company's vehicles comprise cargo and passenger vehicles, school buses, ambulances, shuttle buses, work trucks, city buses, and motorcoaches. It also offers charging systems and charging infrastructure solutions for commercial medium duty vans and motorcoach fleets. The company was founded in 2008 and is headquartered in Loveland, Colorado.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/14/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.12
- Trailing P/E Ratio 1.4553571428571
- Forward P/E Ratio 1.4553571428571
- P/E Growth 1.4553571428571
- Net Income $15.17 M
Income Statement
Quarterly
Annual
Latest News of ZEV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Miplyffa, in combination with Johnson & Johnson's enzyme inhibitor Zavesca, is approved by the FDA to treat neurological symptoms in adults and children with NPC, a rare genetic disease. This marks a ...
By Yahoo! Finance | 1 week ago -
US FDA approves Zevra's treatment for rare genetic disease
The U.S. FDA approved Zevra Therapeutics' drug for Neimann-Pick disease type C, a rare genetic disorder. The oral drug, Miplyffa, can now be used in combination with miglustat to treat neurological sy...
By Yahoo! Finance | 1 week ago -
Ana Maria Knezevich missing: Federal authorities say no blood found at scene where Florida woman disappeared
David Knezevich's attorney denies involvement in his wife's disappearance in Spain. Lack of forensic evidence and inconsistent findings raise doubts about the case against him. Ana and David ran a suc...
By Fox News | 1 month ago